ROLE OF HYPOXIA INDUCIBLE FACTOR-1? IN LYMPH NODE METASTASIS OF BREAST CANCER

Authors

  • Galuh Widowati Faculty of Medicine, Universitas Kristen Duta Wacana, Indonesia

DOI:

https://doi.org/10.21460/bikdw.v9i2.1014

Keywords:

Hypoxia, HIF-1α, lymph node metastasis, breast cancer

Abstract

Background: Lymph node metastasis in breast cancer is a clinical parameter used to predict a patient’s prognosis. Lymph node metastasis is affected by numerous factors, one of which is hypoxic conditions that trigger the expression of HIF-1?, a transcription factor expressed by cells in hypoxia. To date, the role of HIF-1? in lymph node metastasis in breast cancer requires further research. Objective: This review aimed to describe the possible role of HIF-1? in breast cancer lymph node metastasis. Methods: PubMed and Google Scholar databases were searched for articles using Boolean operations with keywords related to HIF-1? expression and lymph node metastasis of breast cancer. We have limited the 10 years of publication to be included in this review. Results: HIF-1? has the potential to induce epithelial-mesenchymal transition, extracellular matrix invasion, matrix degradation, and lymphangiogenesis through various target gene expression and signaling pathways, leading to lymph node metastasis of breast cancer cells.

References

Lee, E., Fertig, E., Jin, K. et. al., 2015. Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis. Nat Commun. 5 :4715

Semenza, G.L., 2017. The hypoxic tumor microenvironment : A driving force for breast cancer progression. Biochim Biophy Acta. 2863(3): 382-391.

Petrova, V., Annicchiarico-Petruzzelli, M., Melino, G., Amelio, I., 2018. The hypoxic tumour microenvironment. Oncogenesis 7:10

Kozal, K., Krze?lak, A., 2022. The Role of Hypoxia-Inducible Factor Isoforms In Breast Cancer and Perspectives on Their Inhibition In Therapy. Cancers (Basel) 14(18):4518

Ju, J., Godet, I., Ye, I.C., et.al., 2017. Hypoxia selectivity enhances integrin receptor expressiom to promote metastasis. Mol Cancer Res. 15(6): 732-734

Chao, Y., Zhang-Feng. Z., Sheng-Peng., W, Chi-Teng, V., Bin, Y., Yi-Tai, W., 2021. HIF-1 : Structure, Biologi And Natural Modulators. Chin J Nat. Med 19(7): 521 – 527

Wicks, E., And Semenza, G. L., 2022. Hypoxia-Inducible Factors : Cancer Progression And Clinical Translation. J Clin Invest. 132(11): E159839

Nie, C,, Lv, H., Bie, L., Hou, H., Chen, X., 2018. Hypoxia-Inducible Factor 1-Alpha Expression Correlates With Response To Neoadjuvant Chemotherapy In Women With Breast Cancer. Medicine (Baltimore) 97(51):E13551.

Cui, J., Jiang, H., 2019. Prediction Of Postoperative Survival of Triple-Negative Breast Cancer Based on Nomogram Model Combined with Expression Of HIF1? And C Myc. Medicine (Baltimore).98(40): e17370.

Zhao, Z., Mu, H., Li, Y., Liu, Y., Zou, J., Zhu, Y., 2020. Clinicopathological And Prognostic Value Of Hypoxia-Inducible Factor-1? In Breast Cancer : A Meta Analysis Including 5177 Patients. Clinical And Translational Oncology 22: 18921906.

Kozakiewicz, A. B., Sobol, M., Patera, J., 2016. Expression Of Hypoxia-Inducible Factor 1? In Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation With Steroid Receptors, HER2 And EPO-R. Adv Clin Exp Med 25, 4, 741–750

Gunawan, I., Hatta, M., Benyamin, A. F., Islam, A. A., 2020. The Hypoxic Response Expression as Survival Biomarkers in Treatment-Naïve Advanced Breast Cancer. Asian Pac J Cancer Prev; 21(3), 629-637.

Wang, L., Zhang, S., And Wang, X., 2021. The Metabolic Mechanisms of Breast Cancer Metastasis. Front. Oncol 10:602416.

Ruscitto, F., Roda, N., Priami, C., Migliaccio, E., Pelicci, P.G., 2022. Beyond Genetics: Metastasis As an Adaptive Response in Breast Cancer. International Journal Of Molecular Sciences. 23(11):6271.

Liu, Q., Guan, C., liu, C., Li, H., Wu, J., Sun, C., 2022. Targeting hypoxia-inducible factor-1alpha : A new strategy for triple-negative breast cancer therapi. Biomedicine & Phramacotherapy. 156 : 113861

Li, Z., Semenza, G.L., Zhang, H., 2015. Hypoxia-inducible factor 1 and breast cancer metastasis. Biomed & Biotechnol. 16(1): 32-43

Shao, C., Zhang, J., Fu, J., Ling, F., 2015. The potential role of Brachyury in inducing epithelial-to-mesenchymal transition (EMT) and HIF-1? expression in breast cance cells. Biochemical and Biophysical Research Communication. 467 : 1083-1089

Dai, T., Rosario, S.R., Katsuta, E., et.al., 2022. Hypoxic activation of PFKFB4 in breast tumor microenvironment shapes metabolic and cellular plasticity to accentuate metastatic competence. Cell Rep. 41(10):111756

Morfoisse, F., Renaud, E., Hantelys, F., Prats, A., Garmy-Susini, B., 2015. Roleof hypoxia and vascular endothelial growth factor in lymphangiogenesis. Molecular & Cellular Oncology 2:4.

Gao, T., Li, J., Lu, Y., et. al., 2016. The mechanism between epithelial mesenchymal transition in breast cancer and hypoxia microenvironment. Biomedicine & Pharmacotherapy. 80: 393-405

Lee, E., Fertig, E., Jin, K., et.al., 2015. Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis. Nat Commun. 5:4715

Hegde, M., Daimary, U.D., Kumar, A. et. al., 2022. STAT3/HIF1A and EMT specific transcription factors regulated genes: Novel predictors of breast cancer metastasis. Gene 818:146245

Cai,F., Xu, C., Pan, X., et. al., 2016. Prognostic value of plasma levels of HIF-1a and PGC-1a in breast cancer. Oncotarget. 7: 77793-77806

Jo¨Gi, A., Ehinger, A., Hartman, L., Alkner, S., 2019. Expression Of HIF-1? Is Related to A Poor Prognosis and Tamoxifen Resistance in Contralalateral Breast Cancer. Plos ONE 14(12): E0226150.

Chen, M., Liu, Z., Zheng, K., Hu, C., Peng, P., 2024. The potential mechanism of HIF-1? and CD147 in the development of triple-negative breast cancer. Medicine (Baltimore). 103(23):e38434.

Sharma, M., Piplani, S., Madan, M., Manjari, M., Garg, S., Kaur, K., 2017. Hypoxia-induced factor-1 alpha, vascular endothelial growth factor expression in BRCA1-related breast cancer: A prospective study in tertiary care hospital. Indian J Pathol Microbiol. 60(4):469-474

Lian, Y.E., Wu, D., Huang, J.P., et al., 2020. Effect of HIF-1? and BRD4 on autophagy level of breast cancer cell in hypoxic microenvironment]. Zhonghua Bing Li Xue Za Zhi. 49(12):1294-1299.

Wang, R., Godet, I., Yang, Y., et. al., 2021. Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis. Proc Natl Acad Sci U S A. 118(19):e2020490118.

Luo, S., Jiang, Y., Anfu, Z., et.al., 2022. Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review. Front Pharmacol. 13:1064661

Zhi, S., Chen, C., Huang, H., Zhang, Z., Zeng, F., Zhang, S., 2024. Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment. Front Immunol.15:1370800

Anwar, S.L., Raharjo, C.A., Herviastuti, R. et al. 2019. Pathological Profiles and Clinical Management Challenges of Breast Cancer Emerging in Young Women in Indonesia: A Hospital-Based Study. BMC Women's Health 19, 28.

Cao, Q., Mushajiang, M., Tang, C.Q., Ai, X.Q., 2023. Role Of Hypoxia-Inducible Factor-1? And Surviving in Breast Cancer Recurrence and Prognosis. Heliyon. 9(3) : e14132

Morfoisse, F., Kuchnio, A., Frainay, C., Et.Al., 2014. Hypoxia Induces VEGF-C Expression In Metastatic Tumor Cells Via A HIF-1? Independent Translation - Mediated Mechanism. Cell Reports 6 : 155 – 167.

Wang, Y., Zhang, G., Han, J., 2019. HIF1A-AS2 Predicts Poor Prognosis And Regulates Cell Migration and Invasion in Triple-Negative Breast Cancer. Journal Of Cellular Biochemistry, 120(6), 10513–10518.

Yang, Z.J., Yu, Y., Hou, X.W., Chi, J.R., Ge, J., Wang, X., Cao, X.C., 2017. The Prognostic Value of Node Status in Different Breast Cancer Subtypes. Oncotarget 8(3):4563-4571

Zhang, Z., Han, Y., Nian, Q., Et.Al., 2015. Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis And Unfavorable Prognosis In Young Breast Cancer Ptients (? 35 Years). Plos ONE 10(12): E0144376.

Downloads

Published

2024-12-30

Citation Check